Teva is a major global generic medicines company headquartered in Israel, with a large portfolio of off-patent drugs sold worldwide. It also develops and markets selected specialty and complex products, including treatments in areas such as central nervous system disorders and respiratory disease. Generics volume, complex formulations and a broad retail and institutional customer base define its position in affordable pharmaceuticals.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 4,176 | — | 282 | — |
| Q3 2025 | 4,480 | — | 433 | — |
| Q4 2025 | 4,711 | — | 480 | — |
| Q1 2026 | 3,981 | — | 369 | — |
| Q2 2026 | 4,142 | -0.8% | -576 | -304.3% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Vylor Inc. (VYLR), ArcelorMittal S.A. (MT), Vivmark Residential (VMRK), Rockwell Automation, Inc. (ROK), Ciena Corporation (CIEN), Franco-Nevada Corporation (FNV)